Bone marrow stem cell transplants are seen as a potential treatment for ALS disease.
FDA approves the first new drug for ALS treatment in many years.
Doctors in the Netherlands claim they have successfully tested a new implantable computer-brain interface that allows patients to spell messages.
Researchers from Ben-Gurion University of the Negev (BGU) have published a new study that describes a novel molecular mechanism that could lead to the development of new therapies for Amyotrophic Lateral Sclerosis (ALS).
A recent study reveals that a type of cell in the central nervous system can "go rogue" and destroy motor neurons in people with ALS.
Researchers were able to prevent the death of neurons that causes ALS by introducing a genetic mutation to prevent the SOD1 protein from clumping.